(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DCODE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DCODE

ST13

US500000079257674

Class

1, 5

Filing

79257674

Registration

6026139

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

50

Latest update

08/05/2026

Trademark type

Word

Nice classes

1, 5

Filing date

12/06/2018

Registration date

04/07/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/05/2026

Last transaction

08/05/2026

Responsible office

United States Patent and Trademark Office

Status code

708

Official register

Principal Register

Drawing code

4

Owner type

24

Owner location

Virum, DK

Examiner

FALK, JONATHAN ROBERT

Current location

Historical data usage

Holders and representatives

Holders

I. A. (pessoa física)
I. A. (pessoa física)

Representatives

Julie A. Greenberg Fishman Stewart PLLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals used in diagnosticsindustry and scienceother than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagentsmonoclonal antibodiesreagentsdiagnostic agentscontrol reagentsDNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapycancer vaccinesborrelia vaccinesTB-vaccinesHIV-vaccinesCMV-vaccines and other vaccinesfor analysis for research purposes of T-cell lymphomaT-cell infiltration of solid tumors and tissuefor analysis for research purposes of infectious diseasesautoimmunity and for use in connection with toxicological studies and research in relation to transplantationimmune monitoringvaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes

Class 5

Preparations for pharmaceutical purposes for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccinesimmunotherapeutics and cellular therapiesincluding cancer vaccines and immunotherapeuticsborrelia vaccinesTB-vaccinesHIV-vaccines and CMV-vaccinesT-cell therapiesfor use in connection with cancer therapy and other medical therapiesfor analysis and treatment of T-cell lymphomaT-cell infiltration of solid tumors and tissuefor infectious diseasesfor use in connection with medical procedures and diagnosistransplantationimmune monitoringvaccines and T-cell monitoring

Publications

History of USPTO decisions and trademark events.

50 publications found

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

08/05/2026

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

08/05/2026

PRAN

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED

08/05/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/27/2026

ES75

TEAS SECTION 71 & 15 RECEIVED

04/08/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

04/07/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/09/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/09/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/09/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/12/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/12/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/12/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/14/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/14/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

04/14/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/14/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/14/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/14/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/02/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

01/21/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/12/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/12/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/12/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/12/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/12/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/05/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/14/2020

FIMP

FINAL DISPOSITION PROCESSED

08/14/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/07/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

04/07/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/21/2020

PUBO

PUBLISHED FOR OPPOSITION

01/21/2020

GPNX

NOTIFICATION PROCESSED BY IB

01/17/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/01/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/01/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/01/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/17/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/17/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/17/2019

ALIE

ASSIGNED TO LIE

12/11/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/29/2019

RFNP

REFUSAL PROCESSED BY IB

06/22/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/05/2019

RFRR

REFUSAL PROCESSED BY MPU

06/05/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/11/2019

CNRT

NON-FINAL ACTION WRITTEN

05/10/2019

MAFR

APPLICATION FILING RECEIPT MAILED

05/10/2019

DOCK

ASSIGNED TO EXAMINER

05/06/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/06/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/02/2019

Continuous trademark protection

Get notified about every new filing that threatens DCODE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.